Maple Capital

Maple Capital concentrates on pre-seed and seed rounds, typically acting as the first or among the very first institutional checks into a startup. The firm does not publicly describe a growth-stage or crossover strategy; its capital is deployed at the point of company formation or immediately after, aligning with technical founders in the earliest phases of product development and initial customer validation.

While Maple Capital does not publish a formal exclusion list, the firm's observed activity points away from hardware-intensive deep-tech, heavily regulated healthcare, and consumer-marketplace models with long paths to revenue. Its focus stays on asset-light enterprise software, applied AI/ML, and cybersecurity — areas where the time from technical insight to enterprise buyer is shortest.

The firm has not publicly disclosed its partnership composition or named its investment committee members. Seed-stage firms in the Tel Aviv ecosystem often operate with one or two general partners making decisions together with operator-advisors; Maple Capital's specific governance structure remains unpublished in the public record.

The firm sources primarily through direct relationships with repeat technical founders, particularly those exiting Israeli elite compute-intelligence units and deep-engineering labs. This operator-proximity model — common among top-decile Israeli seed funds — typically involves pre-company engagement with founders while they are still inside larger technology organizations, giving the fund early visibility before a formal fundraise process begins.

Maple Capital is structured as a venture capital firm managing external capital, not a single-family office. The firm's vehicle is organized for direct early-stage investments with capacity to follow on, consistent with the standard limited-partner fund model used by institutional seed investors in Israel.